NYSE:RAD

Rite Aid Stock Forecast, Price & News

$19.05
-0.37 (-1.91 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.97
Now: $19.05
$19.88
50-Day Range
$18.57
MA: $21.59
$27.38
52-Week Range
$8.85
Now: $19.05
$32.48
Volume2.29 million shs
Average Volume2.66 million shs
Market Capitalization$1.05 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.01
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program. As of April 21, 2020, the company operated approximately 2,400 retail pharmacy locations in 18 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Rite Aid logo

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP76775410
Phone717-761-2633
Employees29,840
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.93 billion
Cash Flow$6.48 per share
Book Value$11.06 per share

Profitability

Net Income$-452,170,000.00

Miscellaneous

Market Cap$1.05 billion
Next Earnings Date4/15/2021 (Confirmed)
OptionableOptionable

Headlines

Rite Aid (NYSE:RAD) Shares Down 5.1%
April 8, 2021 |  americanbankingnews.com
Rite Aid (RAD) Set to Announce Quarterly Earnings on Thursday
April 8, 2021 |  americanbankingnews.com
Rite Aid (NYSE:RAD) Shares Up 6.2%
April 5, 2021 |  americanbankingnews.com
What Rite Aid $RAD is Telling us About its Future
March 31, 2021 |  marketwatch.com
Rite Aid: The Easy Money Has Been Made
March 27, 2021 |  seekingalpha.com
Why Rite Aid Stock Plunged Today
March 25, 2021 |  fool.com
Rite Aid (NYSE:RAD) Shares Gap Down to $23.34
March 25, 2021 |  americanbankingnews.com
See More Headlines

MarketRank

Overall MarketRank

0.83 out of 5 stars

Retail/Wholesale Sector

235th out of 383 stocks

Drug Stores & Proprietary Stores Industry

7th out of 14 stocks

Analyst Opinion: 0.8Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$19.05
-0.37 (-1.91 %)
(As of 04/14/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rite Aid (NYSE:RAD) Frequently Asked Questions

Is Rite Aid a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Rite Aid stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAD, but not buy additional shares or sell existing shares.
View analyst ratings for Rite Aid
or view top-rated stocks.

What stocks does MarketBeat like better than Rite Aid?

Wall Street analysts have given Rite Aid a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Rite Aid wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, April 15th 2021.
View our earnings forecast for Rite Aid
.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Wednesday, December, 16th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.45. The firm had revenue of $6.12 billion for the quarter, compared to analysts' expectations of $5.84 billion. Rite Aid had a negative net margin of 1.66% and a positive trailing twelve-month return on equity of 2.12%. The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.54 earnings per share.
View Rite Aid's earnings history
.

How has Rite Aid's stock price been impacted by Coronavirus?

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RAD stock has increased by 34.8% and is now trading at $19.05.
View which stocks have been most impacted by COVID-19
.

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Rite Aid shares reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid updated its FY 2021 After-Hours earnings guidance on Wednesday, March, 24th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $23.975-24 billion, compared to the consensus revenue estimate of $24.07 billion.

What price target have analysts set for RAD?

3 Wall Street analysts have issued 1-year price targets for Rite Aid's stock. Their forecasts range from $6.00 to $27.00. On average, they anticipate Rite Aid's stock price to reach $16.67 in the next twelve months. This suggests that the stock has a possible downside of 12.5%.
View analysts' price targets for Rite Aid
or view top-rated stocks among Wall Street analysts.

Who are Rite Aid's key executives?

Rite Aid's management team includes the following people:
  • Ms. Heyward Rutledge Donigan B.A., Pres CEO & Director (Age 60, Pay $4.62M)
  • Mr. Matthew Schroeder, CFO & Exec. VP (Age 51, Pay $1.13M)
  • Mr. James Joseph Peters Jr., Chief Operating Officer (Age 49, Pay $558.62k)
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP & Chief Pharmacy Officer (Age 51, Pay $1.25M)
  • Mr. Brian T. Hoover, Chief Accounting Officer (Age 56)
  • Mr. Justin L. Mennen, Exec. VP & Chief Information Officer (Age 40)
  • Byron Purcell, Sr. Director of Treasury Services & Investor Relations
  • Mr. Trent Kruse, Sr. VP of Investor Relations & Treasury
  • Mr. Paul D. Gilbert, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Ms. Susan K. Henderson, Chief Communications Officer & Sr. VP (Age 68)

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid CEO Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among Rite Aid's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Rite Aid's key competitors?

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), (CELG), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $19.05.

How much money does Rite Aid make?

Rite Aid has a market capitalization of $1.05 billion and generates $21.93 billion in revenue each year. The company earns $-452,170,000.00 in net income (profit) each year or $0.15 on an earnings per share basis.

How many employees does Rite Aid have?

Rite Aid employs 29,840 workers across the globe.

What is Rite Aid's official website?

The official website for Rite Aid is www.riteaid.com.

Where are Rite Aid's headquarters?

Rite Aid is headquartered at 30 Hunter Lane, Camp Hill PA, 17105.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]


This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.